ASX - By Stock
|
IBX |
Re:
JOURNEY to 50c plus
|
|
rgc68
|
605 |
229K |
2 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
605
|
229K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
JOURNEY to 50c plus
|
|
rgc68
|
605 |
229K |
1 |
25/09/22 |
25/09/22 |
ASX - By Stock
|
605
|
229K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
ONCOSIL MEDICAL LTD vs SIRTEX MEDICAL?
|
|
rgc68
|
16 |
9.7K |
1 |
25/04/22 |
25/04/22 |
ASX - By Stock
|
16
|
9.7K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Prof. Ricky Sharma appointed to the Board of OncoSil
|
|
rgc68
|
11 |
5.6K |
2 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
11
|
5.6K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil achieves first commercial sale
|
|
rgc68
|
42 |
14K |
0 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
42
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil achieves first commercial sale
|
|
rgc68
|
42 |
14K |
0 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
42
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL Corpse
|
|
rgc68
|
49 |
20K |
4 |
09/08/20 |
09/08/20 |
ASX - By Stock
|
49
|
20K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
OSL Corpse
|
|
rgc68
|
49 |
20K |
3 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
49
|
20K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Files For Registration Of Oncosiltm Device In U.S. Market
|
|
rgc68
|
28 |
10K |
2 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
28
|
10K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Files For Registration Of Oncosiltm Device In U.S. Market
|
|
rgc68
|
28 |
10K |
5 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
28
|
10K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
OSL Top Pick for FY21
|
|
rgc68
|
17 |
8.5K |
1 |
26/07/20 |
26/07/20 |
ASX - By Stock
|
17
|
8.5K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OSL Top Pick for FY21
|
|
rgc68
|
17 |
8.5K |
0 |
25/07/20 |
25/07/20 |
ASX - By Stock
|
17
|
8.5K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL Top Pick for FY21
|
|
rgc68
|
17 |
8.5K |
3 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
17
|
8.5K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
OSL Top Pick for FY21
|
|
rgc68
|
17 |
8.5K |
3 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
17
|
8.5K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
OSL Top Pick for FY21
|
|
rgc68
|
17 |
8.5K |
9 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
17
|
8.5K
|
9
|
|
ASX - By Stock
|
IMC |
Re:
Sanyal's Phase 2 ASH Trial
|
|
rgc68
|
1 |
735 |
1 |
10/09/18 |
10/09/18 |
ASX - By Stock
|
1
|
735
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Jack in The Australian today - $$ to come
|
|
rgc68
|
132 |
44K |
0 |
25/04/18 |
25/04/18 |
ASX - By Stock
|
132
|
44K
|
0
|
|
ASX - By Stock
|
TRI |
Re:
Jack in The Australian today - $$ to come
|
|
rgc68
|
132 |
44K |
3 |
08/04/18 |
08/04/18 |
ASX - By Stock
|
132
|
44K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
.85-95 ASX ($25-$30 USD) by June 2018
|
|
rgc68
|
51 |
19K |
2 |
24/03/18 |
24/03/18 |
ASX - By Stock
|
51
|
19K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
.85-95 ASX ($25-$30 USD) by June 2018
|
|
rgc68
|
51 |
19K |
14 |
24/03/18 |
24/03/18 |
ASX - By Stock
|
51
|
19K
|
14
|
|
ASX - By Stock
|
IMC |
Re:
.85-95 ASX ($25-$30 USD) by June 2018
|
|
rgc68
|
51 |
19K |
0 |
22/03/18 |
22/03/18 |
ASX - By Stock
|
51
|
19K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Presentation-Surgical Resection Outcomes and Capital Raising
|
|
rgc68
|
46 |
30K |
1 |
22/03/18 |
22/03/18 |
ASX - By Stock
|
46
|
30K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Presentation-Surgical Resection Outcomes and Capital Raising
|
|
rgc68
|
46 |
30K |
1 |
21/03/18 |
21/03/18 |
ASX - By Stock
|
46
|
30K
|
1
|
|
ASX - By Stock
|
RHT |
Re:
14 Year share price value
|
|
rgc68
|
3 |
1.0K |
0 |
29/09/17 |
29/09/17 |
ASX - By Stock
|
3
|
1.0K
|
0
|
|
ASX - By Stock
|
TRI |
Re:
Mr Phelps
|
|
rgc68
|
35 |
11K |
3 |
10/06/17 |
10/06/17 |
ASX - By Stock
|
35
|
11K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Advisor appointed to advance commercialisation in China
|
|
rgc68
|
18 |
9.2K |
3 |
10/06/17 |
10/06/17 |
ASX - By Stock
|
18
|
9.2K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Heading for Cure HIV ???
|
|
rgc68
|
27 |
10K |
2 |
06/02/17 |
06/02/17 |
ASX - By Stock
|
27
|
10K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Heading for Cure HIV ???
|
|
rgc68
|
27 |
10K |
3 |
06/02/17 |
06/02/17 |
ASX - By Stock
|
27
|
10K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 2 February 2017
|
|
rgc68
|
60 |
31K |
5 |
03/02/17 |
03/02/17 |
ASX - By Stock
|
60
|
31K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: AGM Presentation
|
|
rgc68
|
28 |
9.5K |
0 |
10/01/17 |
10/01/17 |
ASX - By Stock
|
28
|
9.5K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Pancreatic cancer clinical study update
|
|
rgc68
|
29 |
15K |
1 |
10/01/17 |
10/01/17 |
ASX - By Stock
|
29
|
15K
|
1
|
|
Charts
|
TRI |
Re:
Bullish on MEB
|
|
rgc68
|
167 |
38K |
3 |
18/05/16 |
18/05/16 |
Charts
|
167
|
38K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: $1.5 Million R&D Tax Rebate-BIT.AX
|
|
rgc68
|
50 |
10K |
3 |
20/04/16 |
20/04/16 |
ASX - By Stock
|
50
|
10K
|
3
|
|
ASX - By Stock
|
BLT |
Re:
6 week HCV cure with Harvoni
|
|
rgc68
|
2 |
952 |
0 |
16/04/16 |
16/04/16 |
ASX - By Stock
|
2
|
952
|
0
|
|
ASX - By Stock
|
BIT |
Re:
New Billion Dollar Drug Deal
|
|
rgc68
|
25 |
4.9K |
5 |
06/04/16 |
06/04/16 |
ASX - By Stock
|
25
|
4.9K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
New Billion Dollar Drug Deal
|
|
rgc68
|
25 |
4.9K |
3 |
05/04/16 |
05/04/16 |
ASX - By Stock
|
25
|
4.9K
|
3
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Presentations for investor briefings commencing 5 April-MEB.AX
|
|
rgc68
|
5 |
1.4K |
0 |
04/04/16 |
04/04/16 |
ASX - By Stock
|
5
|
1.4K
|
0
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Successful Pre-Submission Meeting with the US FDA
|
|
rgc68
|
5 |
1.9K |
0 |
04/04/16 |
04/04/16 |
ASX - By Stock
|
5
|
1.9K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Thoughts
|
|
rgc68
|
47 |
8.0K |
1 |
02/04/16 |
02/04/16 |
ASX - By Stock
|
47
|
8.0K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Thoughts
|
|
rgc68
|
47 |
8.0K |
4 |
01/04/16 |
01/04/16 |
ASX - By Stock
|
47
|
8.0K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Thoughts
|
|
rgc68
|
47 |
8.0K |
5 |
01/04/16 |
01/04/16 |
ASX - By Stock
|
47
|
8.0K
|
5
|
|
ASX - By Stock
|
BIT |
further perspective on Biotron
|
|
rgc68
|
0 |
541 |
4 |
20/03/16 |
20/03/16 |
ASX - By Stock
|
0
|
541
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Capital raising possiblity
|
|
rgc68
|
12 |
3.0K |
1 |
19/03/16 |
19/03/16 |
ASX - By Stock
|
12
|
3.0K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Capital raising possiblity
|
|
rgc68
|
12 |
3.0K |
0 |
19/03/16 |
19/03/16 |
ASX - By Stock
|
12
|
3.0K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Capital raising possiblity
|
|
rgc68
|
12 |
3.0K |
2 |
19/03/16 |
19/03/16 |
ASX - By Stock
|
12
|
3.0K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Capital raising possiblity
|
|
rgc68
|
12 |
3.0K |
1 |
18/03/16 |
18/03/16 |
ASX - By Stock
|
12
|
3.0K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Capital raising possiblity
|
|
rgc68
|
12 |
3.0K |
1 |
18/03/16 |
18/03/16 |
ASX - By Stock
|
12
|
3.0K
|
1
|
|
ASX - By Stock
|
BIT |
too little too late
|
|
rgc68
|
0 |
430 |
2 |
17/03/16 |
17/03/16 |
ASX - By Stock
|
0
|
430
|
2
|
|
ASX - By Stock
|
BLT |
Re:
Ann: POSITIVE HBV IN VIVO DATA
|
|
rgc68
|
96 |
33K |
4 |
11/03/16 |
11/03/16 |
ASX - By Stock
|
96
|
33K
|
4
|
|
ASX - By Stock
|
BLT |
Re:
Ann: POSITIVE HBV IN VIVO DATA
|
|
rgc68
|
96 |
33K |
2 |
11/03/16 |
11/03/16 |
ASX - By Stock
|
96
|
33K
|
2
|
|